ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

PALI Palisade Bio Inc

6.36
-0.10 (-1.55%)
2024年5月18日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Palisade Bio Inc PALI NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.10 -1.55% 6.36 13:00:11
始値 安値 高値 終値 前日終値
6.42 5.94 6.4383 6.36 6.46
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1805:51EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/5/1705:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/5/1421:05GLOBEPalisade Bio Reports First Quarter 2024 Financial Results..
2024/5/1405:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1105:52EDGAR2Form 8-K - Current report
2024/5/0907:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0907:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0906:06EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/5/0721:30GLOBEPalisade Bio Appoints Margery Fischbein to its Board of..
2024/5/0720:30GLOBEPalisade Bio Announces Closing of $4 Million Private..
2024/5/0221:30GLOBEPalisade Bio Announces $4 Million Private Placement Priced..
2024/5/0121:30GLOBEPalisade Bio’s Lead Product Candidate, PALI-2108..
2024/4/2321:30GLOBEPalisade Bio Enters into Strategic Collaboration with Strand..
2024/4/1621:30GLOBEPalisade Bio Successfully Demonstrates Bioactivation of..
2024/4/1122:15GLOBEPalisade Bio to Participate in the Virtual Investor Lunch..
2024/4/1021:15GLOBEPalisade Bio Presents Development Overview of PALI-2108 at..
2024/4/0406:30GLOBEPalisade Bio Announces 1-for-15 Reverse Stock Split
2024/3/2721:00GLOBEPalisade Bio Reports Year End 2023 Financial Results and..
2024/3/0706:35EDGAR2Form 8-K - Current report
2024/2/1522:35GLOBEPalisade Bio to Present at Digestive Disease Week (DDW) 2024
2024/2/1504:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1410:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1406:38EDGAR2Form 8-K - Current report
2024/2/1405:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1405:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1405:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1405:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1322:35GLOBEPalisade Bio Provides Corporate Update and Reiterates..
2024/2/1006:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0906:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0906:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0904:40GLOBECorrection Notice of Palisade Bio’s Press Release Announcing..
2024/2/0822:05GLOBEPalisade Bio Announces Formation of Clinical Advisory Board..
2024/2/0722:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0707:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/2/0707:00EDGAR2Form DEF 14A - Other definitive proxy statements
2024/2/0700:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0122:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0122:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0120:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/2/0120:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/2/0120:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/2/0120:02EDGAR2Form 8-K - Current report
2024/1/3023:25GLOBEPalisade Bio Announces Exercise of Previously Issued..
2024/1/2922:30EDGAR2Form 8-K - Current report
2024/1/2922:05GLOBEPalisade Bio Announces Positive Preclinical Data of Lead..
2024/1/2706:45EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/1/2706:00EDGAR2Form RW - Registration Withdrawal Request
2024/1/0922:00GLOBEPalisade Bio Selected for Poster Presentation at the 2024..
2024/1/0606:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock